Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Genomic Analysis of Multiresistant Staphylococcus capitis Associated with Neonatal Sepsis.

Carter GP, Ussher JE, Da Silva AG, Baines SL, Heffernan H, Riley TV, Broadbent R, van der Linden A, Lee J, Monk IR, Stinear TP, Howden BP, Williamson DA.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00898-18. doi: 10.1128/AAC.00898-18. Print 2018 Nov.

2.

Global Scale Dissemination of ST93: A Divergent Staphylococcus aureus Epidemic Lineage That Has Recently Emerged From Remote Northern Australia.

van Hal SJ, Steinig EJ, Andersson P, Holden MTG, Harris SR, Nimmo GR, Williamson DA, Heffernan H, Ritchie SR, Kearns AM, Ellington MJ, Dickson E, de Lencastre H, Coombs GW, Bentley SD, Parkhill J, Holt DC, Giffard PM, Tong SYC.

Front Microbiol. 2018 Jul 9;9:1453. doi: 10.3389/fmicb.2018.01453. eCollection 2018.

3.

Antimicrobial resistance among Shigella in New Zealand.

Heffernan H, Woodhouse R, Hewison C, Sherwood J.

N Z Med J. 2018 Jun 22;131(1477):56-62.

PMID:
29927916
4.

Vancomycin-resistant Enterococcus faecium sequence type 796 - rapid international dissemination of a new epidemic clone.

Mahony AA, Buultjens AH, Ballard SA, Grabsch EA, Xie S, Seemann T, Stuart RL, Kotsanas D, Cheng A, Heffernan H, Roberts SA, Coombs GW, Bak N, Ferguson JK, Carter GC, Howden BP, Stinear TP, Johnson PDR.

Antimicrob Resist Infect Control. 2018 Mar 22;7:44. doi: 10.1186/s13756-018-0335-z. eCollection 2018.

5.

Topical Antibiotic Use Coselects for the Carriage of Mobile Genetic Elements Conferring Resistance to Unrelated Antimicrobials in Staphylococcus aureus.

Carter GP, Schultz MB, Baines SL, Gonçalves da Silva A, Heffernan H, Tiong A, Pham PH, Monk IR, Stinear TP, Howden BP, Williamson DA.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e02000-17. doi: 10.1128/AAC.02000-17. Print 2018 Feb.

6.

Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand.

Lee RS, Seemann T, Heffernan H, Kwong JC, Gonçalves da Silva A, Carter GP, Woodhouse R, Dyet KH, Bulach DM, Stinear TP, Howden BP, Williamson DA.

J Antimicrob Chemother. 2018 Feb 1;73(2):353-364. doi: 10.1093/jac/dkx405.

7.

The clear and present danger of carbapenemase-producing Enterobacteriaceae (CPE) in New Zealand: time for a national response plan.

Blakiston M, Heffernan H, Roberts S, Freeman J.

N Z Med J. 2017 Apr 28;130(1454):72-79.

PMID:
28449019
8.

A phylogenomic framework for assessing the global emergence and evolution of clonal complex 398 methicillin-resistant Staphylococcus aureus.

Gonçalves da Silva A, Baines SL, Carter GP, Heffernan H, French NP, Ren X, Seemann T, Bulach D, Kwong J, Stinear TP, Howden BP, Williamson DA.

Microb Genom. 2017 Jan 31;3(1):e000105. doi: 10.1099/mgen.0.000105. eCollection 2017 Jan.

9.

Household transmission of NDM-producing E. coli in New Zealand.

Blakiston M, Roberts SA, Freeman JT, Heffernan H.

N Z Med J. 2017 Mar 24;130(1452):63-65.

PMID:
28337042
10.

Evidence of transmission of an NDM-5-producing Klebsiella pneumoniae in a healthcare facility in New Zealand.

Howard JC, Creighton J, Heffernan H, Werno A.

J Antimicrob Chemother. 2017 Mar 1;72(3):949-951. doi: 10.1093/jac/dkw498. No abstract available.

PMID:
27999016
11.

Isolation of seven distinct carbapenemase-producing Gram-negative organisms from a single patient.

Creighton J, Heffernan H, Howard J.

J Antimicrob Chemother. 2017 Jan;72(1):317-319. Epub 2016 Sep 12. No abstract available.

PMID:
27621176
12.

Neonatal invasive pneumococcal disease: New Zealand experience in the era of pneumococcal vaccination.

Mount V, Burton C, Jackson C, Heffernan H, Best E.

Aust N Z J Obstet Gynaecol. 2017 Jun;57(3):280-285. doi: 10.1111/ajo.12512. Epub 2016 Aug 17.

PMID:
27530965
13.

Rapid Emergence and Evolution of Staphylococcus aureus Clones Harboring fusC-Containing Staphylococcal Cassette Chromosome Elements.

Baines SL, Howden BP, Heffernan H, Stinear TP, Carter GP, Seemann T, Kwong JC, Ritchie SR, Williamson DA.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2359-65. doi: 10.1128/AAC.03020-15. Print 2016 Apr.

15.

Contemporary genomic approaches in the diagnosis and typing of Staphylococcus aureus.

Williamson DA, Heffernan H, Nimmo G.

Pathology. 2015 Apr;47(3):270-5. doi: 10.1097/PAT.0000000000000236. Review.

PMID:
25764206
16.

First cases of KPC-type carbapenemase-producing bacteria in patients in New Zealand hospitals.

Heffernan H, Dyet K, Munroe S, Creighton J, Chan S, Taylor S, Mansell C.

J Glob Antimicrob Resist. 2014 Dec;2(4):330-333. doi: 10.1016/j.jgar.2014.07.002. Epub 2014 Jul 27.

PMID:
27873697
17.

The changing landscape of antimicrobial resistance in New Zealand.

Williamson DA, Heffernan H.

N Z Med J. 2014 Sep 26;127(1403):41-54. Review.

PMID:
25290498
18.

High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.

Williamson DA, Monecke S, Heffernan H, Ritchie SR, Roberts SA, Upton A, Thomas MG, Fraser JD.

Clin Infect Dis. 2014 Nov 15;59(10):1451-4. doi: 10.1093/cid/ciu658. Epub 2014 Aug 18.

PMID:
25139961
19.

Emergence and molecular characterization of clonal complex 398 (CC398) methicillin-resistant Staphylococcus aureus (MRSA) in New Zealand.

Williamson DA, Bakker S, Coombs GW, Tan Hl, Monecke S, Heffernan H.

J Antimicrob Chemother. 2014 May;69(5):1428-30. doi: 10.1093/jac/dkt499. Epub 2013 Dec 22. No abstract available.

PMID:
24366685
20.

Severe Clostridium difficile infection in New Zealand associated with an emerging strain, PCR-ribotype 244.

De Almeida MN, Heffernan H, Dervan A, Bakker S, Freeman JT, Bhally H, Taylor SL, Riley TV, Roberts SA.

N Z Med J. 2013 Aug 16;126(1380):9-14.

PMID:
24126745
21.

Rectal colonization with New Delhi metallo-β-lactamase-1-producing Escherichia coli prior to transrectal ultrasound (TRUS)-guided prostate biopsy.

Williamson DA, Freeman JT, Roberts SA, Heffernan H, Dyet K, Paterson DL, Rogers BA, Sidjabat HE, Masters J.

J Antimicrob Chemother. 2013 Dec;68(12):2957-9. doi: 10.1093/jac/dkt266. Epub 2013 Jul 3. No abstract available.

PMID:
23825384
22.

Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus in New Zealand: rapid emergence of sequence type 5 (ST5)-SCCmec-IV as the dominant community-associated MRSA clone.

Williamson DA, Roberts SA, Ritchie SR, Coombs GW, Fraser JD, Heffernan H.

PLoS One. 2013 Apr 25;8(4):e62020. doi: 10.1371/journal.pone.0062020. Print 2013.

23.

Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals.

Williamson DA, Sidjabat HE, Freeman JT, Roberts SA, Silvey A, Woodhouse R, Mowat E, Dyet K, Paterson DL, Blackmore T, Burns A, Heffernan H.

Int J Antimicrob Agents. 2012 Jun;39(6):529-33. doi: 10.1016/j.ijantimicag.2012.02.017. Epub 2012 Apr 21.

PMID:
22526013
24.

Comparative epidemiology of CTX-M-14 and CTX-M-15 producing Escherichia coli: association with distinct demographic groups in the community in New Zealand.

Freeman JT, Williamson DA, Heffernan H, Smith M, Bower JE, Roberts SA.

Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):2057-60. doi: 10.1007/s10096-011-1540-3. Epub 2012 Jan 23.

PMID:
22271302
25.

Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand.

Williamson DA, Heffernan H, Sidjabat H, Roberts SA, Paterson DL, Smith M, Freeman JT.

J Antimicrob Chemother. 2011 Dec;66(12):2888-90. doi: 10.1093/jac/dkr396. Epub 2011 Sep 19. No abstract available.

PMID:
21933789
26.

High rates of susceptibility to ceftazidime among globally prevalent CTX-M-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria.

Williamson DA, Roberts SA, Smith M, Heffernan H, Tiong A, Pope C, Freeman JT.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):821-4. doi: 10.1007/s10096-011-1380-1. Epub 2011 Sep 6.

PMID:
21894534
27.

Variation in erythromycin and clindamycin resistance patterns between New Zealand and Australian group B streptococcus isolates.

Clifford V, Heffernan HM, Grimwood K, Garland S; Australasian GBS Resistance Study Group.

Aust N Z J Obstet Gynaecol. 2011 Aug;51(4):328-32. doi: 10.1111/j.1479-828X.2011.01302.x. Epub 2011 Mar 16.

PMID:
21806568
28.

Methicillin-resistant Staphylococcus aureus, Samoa, 2007-2008.

Alesana-Slater J, Ritchie SR, Heffernan H, Camp T, Richardson A, Herbison P, Norris P.

Emerg Infect Dis. 2011 Jun;17(6):1023-9. doi: 10.3201/eid/1706.101083.

29.

Background prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the Auckland community.

Upton A, Eyres S, Heffernan H, Taylor S.

N Z Med J. 2011 Apr 15;124(1332):102-4. No abstract available.

PMID:
21747434
30.

Epidemic strains of Clostridium difficile are present in Auckland, New Zealand.

Roberts S, Heffernan H, Al Anbuky N, Richardson A, Swager T, Taylor SL, Bower J, Williamson D, Freeman JT.

N Z Med J. 2011 Apr 15;124(1332):97-101. No abstract available.

PMID:
21747433
31.

Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009.

Roberts S, Heffernan H, Al Anbuky N, Pope C, Paviour S, Camp T, Swager T.

N Z Med J. 2011 Apr 15;124(1332):45-51.

PMID:
21747423
32.

Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.

Heffernan HM, Woodhouse RE, Pope CE, Blackmore TK.

Int J Antimicrob Agents. 2009 Dec;34(6):544-9. doi: 10.1016/j.ijantimicag.2009.07.014. Epub 2009 Sep 11.

PMID:
19748232
33.

Salmonella enterica serotypes and antibiotic susceptibility in New Zealand, 2002-2007.

Broughton EI, Heffernan HM, Coles CL.

Epidemiol Infect. 2010 Mar;138(3):322-9. doi: 10.1017/S0950268809990458. Epub 2009 Aug 5.

PMID:
19653924
34.

CMY-29 and CMY-30, two novel plasmid-mediated AmpC beta-lactamases.

Pope CE, Carter PE, Heffernan HM.

Antimicrob Agents Chemother. 2009 Jul;53(7):3178. doi: 10.1128/AAC.01586-08. Epub 2009 May 4. No abstract available.

35.

Community-onset genitourinary tract infection due to CTX-M-15-Producing Escherichia coli among travelers to the Indian subcontinent in New Zealand.

Freeman JT, McBride SJ, Heffernan H, Bathgate T, Pope C, Ellis-Pegler RB.

Clin Infect Dis. 2008 Sep 1;47(5):689-92. doi: 10.1086/590941.

PMID:
18665816
36.

Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.

Moor CT, Roberts SA, Simmons G, Briggs S, Morris AJ, Smith J, Heffernan H.

J Hosp Infect. 2008 Apr;68(4):355-62. doi: 10.1016/j.jhin.2008.02.003. Epub 2008 Mar 19.

PMID:
18353497
37.

Salmonella serotypes isolated from pet chews in New Zealand.

Wong TL, Thom K, Nicol C, Heffernan H, MacDiarmid S.

J Appl Microbiol. 2007 Oct;103(4):803-10.

38.

High prevalence of CTX-M-15 extended-spectrum beta-lactamase among contacts of patients with shigellosis due to Shigella flexneri carrying CTX-M-15.

Upton A, Mohiuddin J, Bathgate T, Taylor S, Simmons G, Woodhouse R, Heffernan H.

J Antimicrob Chemother. 2007 Oct;60(4):906-8. Epub 2007 Jul 23. No abstract available.

PMID:
17646198
39.

Invasive pneumococcal disease in New Zealand 1998-2005: capsular serotypes and antimicrobial resistance.

Heffernan HM, Martin DR, Woodhouse RE, Morgan J, Blackmore TK.

Epidemiol Infect. 2008 Mar;136(3):352-9. Epub 2007 May 17.

40.

Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.

Heffernan H, Brokenshire M, Woodhouse R, MacCarthy A, Blackmore T.

N Z Med J. 2004 Apr 2;117(1191):U817.

PMID:
15107886
41.

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence.

Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J.

Emerg Infect Dis. 2003 Aug;9(8):978-84.

42.

Religion and health research: interpretation sends wrong message regarding need for hospital chaplains in health care institutions.

Heffernan H.

J Pastoral Care Counsel. 2003 Spring;57(1):79-81. No abstract available.

PMID:
12728766
43.

Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance.

Upton A, Lang S, Heffernan H.

J Antimicrob Chemother. 2003 Mar;51(3):613-7.

PMID:
12615862
44.

Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus.

Adhikari RP, Cook GM, Lamont I, Lang S, Heffernan H, Smith JM.

J Antimicrob Chemother. 2002 Dec;50(6):825-31.

PMID:
12461000
45.

Methicillin resistant Staphylococcus aureus (MRSA) in New Zealand 1988-90.

Heffernan H, Stehr-Green J, Davies H, Brett M, Bowers S.

N Z Med J. 1993 Mar 10;106(951):72-4.

PMID:
8474702
46.

Antibiotic susceptibilities, serotypes and auxotypes of Neisseria gonorrhoeae isolated in New Zealand.

Brett MS, Davies HG, Blockley JR, Heffernan HM.

Genitourin Med. 1992 Oct;68(5):321-4.

47.

Successful intervention in a group A meningococcal outbreak in Auckland, New Zealand.

Lennon D, Gellin B, Hood D, Voss L, Heffernan H, Thakur S.

Pediatr Infect Dis J. 1992 Aug;11(8):617-23.

PMID:
1523071
48.

Federal government calls for computer-based patient records.

Heffernan H.

Comput Healthc. 1992 Jul;13(7):51-2.

PMID:
10119508
49.
50.

Methicillin-resistant Staphylococcus aureus: an increasing threat in New Zealand hospitals.

Martin DR, Heffernan HM, Davies HG.

N Z Med J. 1989 Jul 26;102(872):367-9.

PMID:
2529458

Supplemental Content

Loading ...
Support Center